Mölnlycke Health Care begins $135m US wound care facility expansion

Core Insights - Mölnlycke Health Care is expanding its wound care manufacturing facility in Brunswick, Maine, with an investment of $135 million to enhance production capacity in the US [1][2] - The expansion will incorporate renewable energy solutions, such as wind and solar power, aligning with the company's sustainability targets [1] - The project is expected to increase employment in Maine by approximately 10% over the next five years and will involve local contractors and suppliers [2] Company Strategy - The expansion aligns with Mölnlycke's strategy to localize manufacturing and meet the growing demand from US healthcare providers [2] - CEO Zlatko Rihter emphasized that the expansion reinforces the company's mission to improve wound care solutions and supply resilience [3] Community and Economic Impact - The groundbreaking ceremony was attended by key political figures, highlighting the project's significance for the local community [3] - The expansion is viewed as a win for Mölnlycke, the local community, and ultimately for the patients served [4] Financial Support - Earlier in the year, Mölnlycke signed a $400 million financing agreement with the Swedish Export Credit Corporation to support its growth and development initiatives [4][5]